Allogene Therapeutics Announces Participation in the 44th Annual TD Cowen Health Care Conference

SOUTH SAN FRANCISCO, Calif., Feb. 28, 2024 -- Allogene Therapeutics, Inc. , a clinical-stage biotechnology company pioneering the development of allogeneic CAR T products for cancer and autoimmune...

Related Keywords

Christine Cassiano ,Corporate Affairs Brand Strategy ,Nasdaq ,Allogene Therapeutics Inc ,Health Care Conference On ,Annual Health Care Conference ,South San Francisco ,Forward Looking Statements ,Private Securities Litigation Reform Act ,Allogene Therapeutics ,Investor Contact ,Chief Corporate Affairs ,Brand Strategy ,